Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Reviews on Environmental Health

Editor-in-Chief: Carpenter, David O. / Sly, Peter

Editorial Board: Brugge, Doug / Edwards, John W. / Field, R.William / Garbisu, Carlos / Hales, Simon / Horowitz, Michal / Lawrence, Roderick / Maibach, H.I. / Shaw, Susan / Tao, Shu / Tchounwou, Paul B.


IMPACT FACTOR 2017: 1.284

CiteScore 2017: 1.29

SCImago Journal Rank (SJR) 2017: 0.438
Source Normalized Impact per Paper (SNIP) 2017: 0.603

Online
ISSN
2191-0308
See all formats and pricing
More options …
Volume 33, Issue 4

Issues

Exposure to persistent organic pollutants: impact on women’s health

Banrida WahlangORCID iD: http://orcid.org/0000-0002-4356-1743
Published Online: 2018-08-15 | DOI: https://doi.org/10.1515/reveh-2018-0018

Abstract

This literature review focuses on the causal relationship between persistent organic pollutants (POPs) exposure and women’s health disorders, particularly cancer, cardio-metabolic events and reproductive health. Progressive industrialization has resulted in the production of a multitude of chemicals that are released into the environment on a daily basis. Environmental chemicals or pollutants are not only hazardous to our ecosystem but also lead to various health problems that affect the human population worldwide irrespective of gender, race or age. However, most environmental health studies that have been conducted, until recently, were exclusively biased with regard to sex and gender, beginning with exposure studies that were reported mostly in male, occupational workers and animal studies being carried out mostly in male rodent models. Health-related issues pertaining to women of all age groups have not been studied thoroughly and rather disregarded in most aspects of basic health science research and it is therefore pertinent that we address these limitations in environmental health. The review also addresses studies looking at the associations between health outcomes and exposures to POPs, particularly, polychlorinated biphenyls (PCBs), dioxins and pesticides, reported in cohort studies while accounting for gender differences. Considering that current levels of POPs in women can also impact future generations, informative guidelines related to dietary patterns and exposure history are needed for women of reproductive age. Additionally, occupational cohorts of highly exposed women worldwide, such as women working in manufacturing plants and female pesticide applicators are required to gather more information on population susceptibility and disease pathology.

Keywords: breast cancer; cardiovascular; metabolic; POPs; women

Background

Progressive industrialization and technological globalization have resulted in the production of a multitude of chemicals that are released into the environment on a daily basis. Environmental chemicals or pollutants are not only hazardous to our ecosystem and ecological equilibrium but also lead to various health issues affecting the human population worldwide. Numerous epidemiologic studies have demonstrated that occupational or accidental exposure to organic compounds and metals result in illnesses including cancer, cardiovascular events and pulmonary diseases. Moreover, an extensive amount of scientific research studies has confirmed the toxicological effects of these chemicals in both in vivo and in vitro models. Fundamentally, the health consequences of chemical/pollutant exposure in females are confounded and dictated by biological factors such as menarche, pregnancy, lactation and menopause which are absent when evaluating risk assessment and toxicological profiles simply considering male representatives. The tendency to develop disorders related to breast cancer, fibroids or reproduction is also unique to women’s health. It is also important to keep in mind that the amount and type of exposure such as chronic versus acute and low dose versus high dose also play significant roles when elucidating exposure risks which is another crucial factor, considering that back in the day, women were not necessarily hired for industrial work but rather viewed as caretakers and homemakers. Given all these factors, it appears that health related issues pertaining to women of all age groups have not been extensively studied and rather disregarded in most aspects of basic health science research and it is therefore pertinent that we address these drawbacks and limitations especially in environmental health. So far, a number of organizations including the National Institutes of Health (NIH) and multiple research groups have recognized and acknowledged these discrepancies, especially with evidence of gender- and sex-differences in drug screening (1), (2), thereby stressing on the importance of using both male and female rodent models. This will facilitate risk assessment based on the identity of the subject (gender) and enable identification of biological sexual differences (sex) when investigating disease pathology and progression, drug and chemical toxicity and therapeutic/pharmacological interventions.

This review focuses on the effects of persistent organic pollutants (POPs) in women’s health, with emphasis on cancer, cardio-metabolic events and reproductive health. The review also addresses studies that take gender into account while focusing on POPs, particularly PCBs (polychlorinated biphenyls), dioxins and pesticides. The publications described and cited in the current review were selected from a literature search using the following keywords – “persistent organic pollutant exposure in women”, “effects of persistent organic pollutant exposure on gender”, “persistent organic pollutant exposure and sex differences”, “persistent organic pollutants and transgenerational effects” and related terms. This review also identifies classes of pollutants in relation to health outcomes, because there is a myriad of environmental toxicants that affect human health. Moreover, it is important to review the health effects of not just a single chemical, but rather multiple classes of chemicals or cocktails of environmental pollutants to enable us to better predict their overall behavior as well as offer a more realistic representation of health outcomes from environmental chemical exposure.

Environmental pollutants of interest: POPs

POPs are poly-halogenated organic compounds that persist in the environment due to their resistance to biochemical and photolytic processes (3), (4). POPs comprise numerous artificial chemicals including polychlorinated biphenyls (PCBs), organochlorine pesticides (OCPs), dioxins, brominated flame retardants (BFRs), perfluorinated compounds (PFCs) and polycyclic aromatic hydrocarbons such as benzo(a)pyrene found in coal and tar deposits. Due to their stability and lipophilic nature, POPs bioaccumulate in the adipose tissue of living organisms and climb up the food chain, biomagnify, and sequester in humans (5).

PCBs were manufactured from the 1930 to 1970s and commercially used as dielectric fluids due to their excellent thermodynamic stability. In light of their carcinogenic potency, PCB production has been banned for over three decades in the United States (US) (Toxic Substances Control Act, 1979) and worldwide when the Stockholm Convention on Persistent Organic Pollutants (POPs Treaty) was signed in 2001 and implemented in May 2004, when enough countries had ratified it (6), (7), (8). In fact, 12 POPs, known as the “Dirty Dozen”, including PCBs, were banned from global production and use by the POPs treaty. Table 1A shows all the POPs listed for elimination since 2004. Between 2009 and 2017, the Stockholm Convention added additional chemicals to their list for elimination or restriction including more pesticides, and industrial chemicals comprising agents categorized as BFRs and PFCs (Table 1B) (9), (10), (11). Unlike PCBs, polychlorinated dibenzo-p-dioxins (PCDDs) or simply dioxins are by-products of organochloride manufacturing or incineration of chlorine-containing substances (12). The most toxic member of the dioxin family, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), also inaccurately referred to as “the dioxin” is a known contaminant of Agent Orange, an herbicide used by the US military during the Vietnam War from 1961 to 1971. On the other hand, BFRs are organo-bromine compounds, incorporated into industrial products to reduce their flammability, and such compounds can leak from consumer products leading to human exposure and health risks (13). Experimental studies have shown that conventional BFRs such as polybrominated diphenyl ethers (PBDEs), hexabromocyclododecane and tetrabromobisphenol A can induce endocrine, reproductive and behavioral abnormalities with some human epidemiologic studies confirming these laboratory observations (14), (15). Most PBDEs have been banned while specific exemptions on production and usage have been imposed on other BFRs. Other emerging POPs such as polybrominated dibenzo-p-dioxin and dibenzofuran (PBDDs and PBDFs) occur as trace contaminants in flame retardants (16). Similar to BFRs, PFCs are also hazardous industrial chemicals, and act as fluorosurfactants which are ubiquitously used in Teflon products, water resistant textiles and fire-fighting foam; examples of PFCs include perfluorosulfonic acids and related derivatives (17), (18).

Table 1:

Types of persistent organic pollutants (POPs) under the Stockholm Convention list.

The health implications associated with exposure to POPs can be classified as either acute or chronic, depending on the dose, duration and types of chemicals or mixtures. Historically, human exposures to POPs occurred primarily though occupational or accidental exposures which were generally at high doses over shorter periods of time and viewed as acute exposures. Incidences of mass PCB poisonings were reported where people consumed rice bran oil that was previously contaminated with PCBs and PCDFs during production resulting in accidental exposures, namely, “Yusho disease” or “oil disease” in 1968 that affected 14,000 people in Japan, and “Yu-cheng disease” in 1979 that affected approximately 2000 people in Taiwan (19), (20), (21), (22). These cohorts suffered from multiple disorders including chloracne, ocular lesions and carcinogenesis. Such health effects were also observed in occupational populations that worked at electrical manufacturing plants or dealt with PCB-containing equipment (23), (24), (25), (26). A number of industrial accidents and emissions have resulted in dioxin contamination and exposure. The “Seveso disaster” that took place in Italy in 1976 was an industrial accident that led to the highest exposures of TCDD ever known in residential populations while the use of Agent Orange left major health impacts in the Vietnamese population (27), (28). On the contrary, chronic exposures are normally at lower concentrations and transpire over the person’s lifetime. Chronic exposure to POPS occur predominantly through dietary sources such as consumption of POPs-contaminated sea food (29), (30). Other exposure routes include inhalation, in utero exposures through the mother, and to a lesser extent, through breastfeeding (31), (32). Moreover, serum levels of POPs in humans tend to be higher in women than men despite notions that childbirth and breastfeeding are means of POPs clearance (5), (33). Exposure to POPs can damage the nervous, hormonal, reproductive, and immune systems with very high exposures resulting in mortality (34), (35), (36), (37). While acute exposures to POPs are often associated with birth defects and cancer (22), (23), chronic and background exposures are more frequently associated with metabolic and cardiovascular diseases (38), (39).

Mechanism(s) of action of POPs

Cellular and molecular mechanisms associated with toxicity mediated by exposure to POPs appear to involve multiple receptor pathways (Table 2). In vivo and in vitro studies have demonstrated toxicological effects of POPs in different organ systems and illustrated the various mechanistic facets that eventually influence disease outcomes. The most commonly studied mechanistic pathway of POPs toxicity is the aryl hydrocarbon receptor (AhR) activation pathway, which in due course activates the AhR target gene battery, resulting in undesirable effects (40). The AhR is a ligand-activated transcription factor predominantly expressed in the liver but also found in extra-hepatic tissues; its activation leads to induction of xenobiotic genes such as cytochrome P450 enzymes, CYP1A1 and CYP1A2 (41). Dioxins are potent AhR ligands with TCDD being considered the most toxic, therefore, terms such as “toxic equivalency factor” (TEF) and “toxic equivalency quotient” (TEQ) are used to express the toxicity of dioxins, furans and coplanar or “dioxin-like” PCBs relative to TCDD whose TEF is 1. Apart from xenobiotic metabolism, AhR activation plays a crucial role in developmental pathways such as hematopoiesis and differentiation, hence its activation is also linked to cell cycle pathways, cell proliferation and carcinogenesis (42). Moreover, AhR can cross-talk with the estrogen receptor (ER), nuclear factor kappa B (NF-κB) and nuclear factor (erythroid-derived 2)-like 2-related factor (Nrf2) activation pathways, resulting in anti-estrogenic activities, as well as upregulation of inflammatory cytokines such as interleukins, formation of reactive oxygen species (ROS), and induction of anti-oxidant enzymes which all precede oxidative stress and tissue damage (41), (4345).

Table 2:

General protein-chemical interactions that mediate toxicity.

Other hepatic, xenobiotic receptors namely the pregnane-xenobiotic receptor (PXR) and the constitutive androstane receptor (CAR) are also targets of POPs such as non-coplanar PCBs that are “phenobarbital-like” (46), (47). Endobiotic receptors such as the peroxisome proliferator-activated receptors (PPARs) and the farnesoid-X-receptor (FXR) are also targeted by POPs (48), (49), (50), (51). Activation or inhibition of these hepatic nuclear receptors are associated with metabolic outcomes such as steatosis, dysregulated and altered energy metabolism and obesity; hence such POPs that are capable of influencing energy metabolism have been described the new emerging term “metabolism disrupting chemicals” (52). Multiple POPs have the ability to interfere with production or mimic activity of hormones in the human endocrine system, thereby disrupting thyroid hormone (TH) and endocrine homeostasis. Some POPs, particularly dichlorodiphenyltrichloroethane (DDT) and its metabolite dichlorodiphenyldichloroethylene (DDE), dioxins, PCBs and BFRs are popularly known as “endocrine disrupting chemicals” (EDCs), or xenoestrogens, or environmental hormones (53), (54), (55). Notably, other investigated mechanisms of POPs toxicity include epigenetic modifications, microRNA alterations, interference with epidermal growth factor receptor (EGFR) signaling, agonistic effects on the ryanodine receptor (RyR), and direct effects on pancreas and vascular endothelium (56), (57), (58), (59), (60), (61), (62), (63), (64), (65), (66). Because exposure to POPs consist of a cocktail of chemicals that can interact with more than one biological target, outcomes of POPs exposure therefore result in cancer, endocrine and cardio-metabolic disorders. Furthermore, given their biological targets, women, infants, children, and the elderly appear to be especially vulnerable to certain effects of POPs; for example thyroid diseases are more prevalent in women and the elderly population is more susceptible to dementia (67), (68).

Effects of POPs on cancer

Various studies looking at POPs exposure in women have focused primarily on breast cancer given that it is the most common cancer in females especially in the Western world. Indeed, a number of reports published in more recent years have shown positive associations between risk for developing breast cancer and exposure to pollutants including PCBs, PFCs and dioxin-like chemicals. Although the scientific evidence available up to date contains conflicting results regarding the association of POPs with breast cancer, with some studies stating that there are no significant effects (69), (70), (71); the availability of more diverse cohorts and larger population size with varying exposure levels has however confirmed the role of POPs in breast cancer development.

One of the initial studies published in 1999 reported a link between OCPs and breast cancer risk using a human breast cancer screening model to study toxaphene, also known as Camphechlor which was a replacement for DDT, and two of its congeners (72). Toxaphene was used heavily as an agricultural insecticide in the US and its concentrations is abnormally high in regions of the northern hemisphere such as the Canadian Arctic and the Great Lakes (73). Initially, toxaphene was reported to have a weak estrogenic activity and Stelzer et al. (72) confirmed this OCP’s estrogenic response in MCF7-E3 estrogen sensitive breast cancer cells, suggesting that exposure to mixtures of estrogenic pollutants may account for increases in occurrence of breast cancer with higher incidences in North America (74), (75). A study on the Greenlandic Inuit women population published in 2011 demonstrated a correlation between serum levels of PFCs including perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) with risk for breast cancer (76), (77). Additionally, women with breast cancer also had significantly higher levels of PCBs in the highest quartile. Another study published recently on the Inuit women population where measurements of pollutant levels were carried out during two time periods (2000–2003 and 2011–2014) reported that significant positive associations were reported between breast cancer risk with PCBs and perfluoroalkyl acids (78). The study also reported that the majority of measured compounds including PCBs, DDE, and PFOS declined significantly during the 10-year period, however an increase was observed for the perfluorinated carboxylic acids (PFCAs). The Arctic Inuit population has been a cohort of interest for studying POPs exposure for decades, as this population exhibited the highest body burdens for legacy POPs such as PCBs and hormone-disrupting chemicals, contributed by the traditional Greenlandic marine diet of consuming whale, seal, seabirds and polar bear (79). Additionally, the Inuit population also appear to have a higher frequency of mutation of the tumor suppressor gene (BRCA1 founder mutation) which contributes synergistically to risk for breast cancer (80), (81).

A study carried out with women in India reported an association between breast cancer and OCPs obtained from food consumption. Notably, it was seen that the pesticide levels were higher in younger women compared to older women (82), despite the expectation that POPs clearance occurs through childbirth and lactation (33). Another case-control study in the Alaskan Native population revealed that women with ER- or progesterone receptor (PR)-tumor types tended to have higher concentrations of persistent pesticides (83). A recent study from Spain looking at POPs in serum and adipose tissue of breast cancer patients reported that certain POPs depending on their localization can contribute to breast cancer aggressiveness (84). For example, PCB138 levels in the serum was positively associated with ER and PR expression whereas PCB180 adipose tissue level was positively associated with gene expression of the oncogene, human epidermal growth factor receptor 2 (HER2). Furthermore, a research group studying OCP contamination and risk for breast cancer in a rural Victorian population in Australia confirmed a positive dose-response relationship for heptachlor epoxide while another study in Mexican women indicated a correlation between concentrations of OCPs including hexachlorobenzene and DDT in breast adipose tissue with benign breast tumors (85), (86).

A study in Japanese women demonstrated that elevated serum levels of OCPs and some PCBs were associated with global hypomethylation of leukocyte deoxyribonucleic acid (DNA), which is in alignment with a another study reported in the Greenlandic Inuit population where high serum POP levels were inversely associated with global DNA methylation, indicating that POPs can mediate epigenetics thereby influencing carcinogenesis (87), (88). Also, preliminary findings by Hoyer et al. in a Danish cohort demonstrated that p53 mutations may have a modifying effect on breast cancer risk associated with exposures to OCPs further implicating the possibility of gene-environment interactions for breast cancer (89). To reiterate these findings, a research group identifying patterns for hospitalization of women with breast cancer concluded that residential proximity to waste sites for hazardous chemicals including POPs and volatile organic compounds was a significant contributor to breast cancer hospitalization (90).

Apart from breast cancer, serum total PCB concentration and consumption of sport fish in the Great Lakes area, enriched in PCBs and DDE, have been positively associated with the occurrence of fibroids (91). Fibroids, also known as uterine leiomyomas, are benign tumors that develop from the smooth muscular tissue of the uterus in premenopausal women. Furthermore, women with fibroids also displayed higher mean concentrations of PCBs, PBDEs, DDE and other OCPs in subcutaneous fat, and a number of POPs and their metabolites were detected in the endometrium of premenopausal women who were undergoing hysterectomies for fibroids, implying that POPs body burden may contribute to the pathological development of such hormone-related disorders (91), (92). An exploratory study by Trabert et al. reported positive associations between serum DDE, and six PCB congeners [99, 138, 146, 153, 196, and 206] and the odds for a fibroid diagnosis (93). Studies in Mexico where OCP residues were analyzed in rural Maya women postulated a positive association between OCP residues with the high rates of cervical uterine cancer and breast cancer mortality in the area and also identified higher levels of OCPs like dieldrin and DDE in blood samples of women suffering from cancer of the uterine cervix (94), (95). With regard to endometrial and ovarian cancer, there is a lack of studies to provide evidence for associations, although a study on organochlorine compounds such as DDT provided no significant associations with endometrial cancer risk (96). However, a study carried out in the US on southeast Asian immigrant women looking at DDT and its metabolite DDE, suggested that DDE does affect ovarian function in women eventually altering other endpoints such as fertility, pregnancy and reproductive cancers (97). In addition, another study recently published provided significant associations between adipose tissue levels of POPs such as PCBs and OCPs such as dieldrin and hexachlorobenzene with deep infiltrating endometriosis (98). Interestingly, a study on a Swedish cohort looking at middle-aged and elderly women established no significant risk between dietary PCB exposures and incidences of breast, endometrial or ovarian cancer (99), indicating the importance of type and time of exposure as factors for predicting diseases risks.

The number of studies investigating effects of POPs on other types of cancer other than breast cancer, specifically in women, is extremely scarce with reports of cancer incidences evaluated mostly for pesticide exposures. The Seveso Women’s Health Study reported that high dioxin exposures can lead to multi-site cancers (100). Also, the Norwegian Women and Cancer Study elucidated the risk of fish liver consumption, which is a popular food type in Norway, with incidences of total cancer and cancer of the breast, uterus and colon in women but the results from this randomly selected population-based study sample reported no significant dose-effects (101). In fact, the research group reported that fish liver consumption was correlated with decreased risk for total cancer. Another study in California residents looking at OCP exposure and risk for hepatocellular carcinoma found that pesticide exposures were associated with a higher risk of developing liver cancer in males rather than females (102).

Given the paucity of focus on other types of cancer in women with regards to POPs, it is indeterminant to conclude if exposure to POPs appears to be the biggest risk for breast cancer in women because women are less susceptible to other forms of cancers compared to their male counterparts, or if they are simply more susceptible to hormone-related cancers, or if it is due to the estrogenic and endocrine-disrupting nature of said chemicals. Nonetheless, the insufficiency of studies on the incidences of other cancer types correlated with exposure to POPs that have been established in males such as cancer of the liver, is a prerequisite for investigating other cancer types in POPs cohort studies considering that women may also have varying exposure levels compared to men as well as different receptor potency and target gene battery which can influence toxicological outcomes.

Effects of POPs on cardiovascular diseases

Cardiovascular diseases comprise disorders related to the heart and blood vessels and include coronary artery diseases such as atherosclerosis and myocardial infarction, hypertensive disorders, stroke, cardiomyopathy and thromboembolism. Traditionally, men were thought to be at higher risks for developing heart diseases such as atherosclerosis than women, specifically due to the different effects of sex hormones on metabolism. Men also tend to develop heart diseases at least 10 years earlier than women, or during mid-life, which is popularly considered as the “male disadvantage”. However, there is a common misperception that women are “protected” from heart disorders, given that cardiovascular diseases are a common cause of death for women who were 65 years and older (103). A study evaluating data from the National Health and Nutrition Examination Surveys (NHANES) taken during 1988–1994 and 1999–2004, reported an increased prevalence of myocardial infarction in women from the 1958–1994 cohort (0.7%) over the 1999–2004 cohort (1.0%), which was the opposite in men; and that although mid-life men still had a higher risk for developing cardiovascular events compared to mid-life women, this age gap has been narrowing in recent years (104). A plausible explanation for the shift in traditional paradigms regarding gender-specific trends in cardiovascular diseases could be due to multiple factors pertaining to dietary habits, lifestyle patterns and environmental exposures.

Epidemiologic studies have documented positive associations between serum concentrations of POPs such as PCBs and DDE with cases of hypertension in many cohorts such as the Anniston population in Alabama, who resided near the Monsanto PCB plant and who have high concentrations of both dioxin-like and non-dioxin-like PCBs (105), (106). The Greenlandic Inuit population also showed increased risk of hypertension with dioxin-like PCB exposure in the younger population while the NHANES 1999–2002 participants showed risk for hypertension with some PCBs [74, 99, 118, 126, 138/158, 170 and 187] (107), (108). Furthermore, Lind et al. reported that circulating levels of DDE were related to prevalent hypertension in the elderly population (109). Again, most of these studies did not address gender specific differences until recently. Nonetheless, the literature available so far, strongly suggest that effects on cardiovascular events impact both men and women, with women being more prone to POPs cardiovascular toxicity in some cases. For example, women from a population of the Seveso cohort in Italy displayed higher risks of mortality related to hypertensive diseases compared to men, indicating that the high accidental exposures to TCDD in the Seveso women 15 years ago resulted in cardiovascular events (110). Ha et al. performed a gender-based study on the NHANES 1999–2002 population and found that both PCDDs and PCDFs were strongly associated with prevalence of newly diagnosed hypertension cases among women, while they showed weaker positive trends of associations in men (111). On the other hand, dioxin-like and non-dioxin-like PCBs, were positively associated with hypertension only in men and tended to be inversely correlated with hypertension in women, while OCPs showed no clear correlation for either gender. It is well known that most AhR agonists that are dioxin-like have anti-estrogenic effects that may have played a role in susceptibility (112). Of interest, however, was the fact that dioxins and dioxin-like compounds with lower TEFs displayed clearer positive trends of associations than dioxins and dioxin-like compounds with higher TEFs (111), suggesting that POPs may mediate their toxic effects in the vasculature through pathways that may be exclusive of AhR binding.

A cross-sectional study in the elderly population in Uppsala, Sweden, by Lind et al. observed that the long-chain perfluroalkyl substances, especially perfluoroundecanoic acid, were related to the presence of overt carotid artery atherosclerosis in women compared to men (113). Moreover, the long-chain PFCs showed positive relationships for echogenicity of the intima-media complex, indicative of increased collagen tissue in the arterial wall in women, suggesting susceptibility to atherosclerotic plaque formation and future cardiovascular events. In addition, Lin et al. reported that higher serum concentrations of PFOS were associated with an increase of carotid intima-media thickness in a cohort of adolescents and young adults, and this effect was more pronounced in women (114).

These epidemiologic data strongly support the argument that POPs can predispose women to cardiovascular diseases. Additionally, the effects seen in women are different from their male counterparts, because certain POPs have the ability to alter sex hormone activity, eventually affecting metabolic parameters such as cholesterol breakdown.

Effects of POPs on metabolic/hepatic events

Interferences in metabolic processes that regulate normal body homeostasis can lead to metabolic disorders, resulting in people suffering from metabolic conditions such as the metabolic syndrome, obesity, diabetes and insulin resistance, dyslipidemia and hepatic malfunctions leading to steatosis and steatohepatitis. The term ‘metabolic syndrome’ was formally coined in 1998 to describe a constellation of risk factors namely abdominal adiposity, hypertension, glucose intolerance/hyperglycemia, hypertriglyceridemia and low high-density lipoprotein levels, therefore leading to diabetes mellitus and cardiovascular morbidity (115). Women are thought to be at greater risk for developing cardiovascular disorders as a consequence of symptoms of the metabolic syndrome as opposed to men (116). Varying situations in the biological life of women such as pregnancy, lactation, menopause and use of hormonal contraception therapy play a role in predicting risks and consequences of such metabolic disorders.

The effects of POPs on diabetes appear controversial yet intriguing, with studies demonstrating a positive correlations between diabetes and dioxins/PCBs, while other studies reported no such correlation with high exposure to POPs and yet other studies reporting associations between PCBs and type 1 diabetes among pregnant women (117), (118). Nonetheless, in terms of diabetes, men did not appear to be as vulnerable as women, per studies in the Seveso cohort where the mortality rate from diabetes was doubled in women living around the accidental exposure area as compared to women residing in the reference area but the same relationship was not observed in men (119). Researchers performing a 24-year follow up study on the Yu-cheng cohort who were victims of a mass PCB and PCDF poisoning in Taiwan, found that diabetes was twice as prevalent in the Yu-cheng women as compared to the reference women population (120); but there was no significant increase in diabetes risk for men in this cohort. Furthermore, a follow-up study on PCB-exposed farmers in Michigan reported that women experienced twice the incidence of self-reported type 2 diabetes when total PCBs exceeded 5 parts per billion; however, there was no such increased diabetic risk for PCB-exposed men (121). In addition, women with high PCBs levels in early pregnancy appeared to have a higher risk for gestational diabetes mellitus, and both PCBs and PBDEs were considered potential modifying risk factors for gestational diabetes (122), (123), (124).

Other than dioxins and PCBs, exposure to DDE was also confirmed as a risk factor for type 2 diabetes in a case-control study performed in southern Sweden in a well-defined population of women who were within the age range of 51–59 (125). Furthermore, DDE, hexachlorobenzene and PCBs (138, 153, 180) were all considered modifiable risk factors for type 2 diabetes and insulin resistance in a cohort of Spanish women with a history of gestational diabetes mellitus (126). Using plasma concentrations and mechanistic modeling, these pollutants were also associated with the prevalence of type 2 diabetes in a cohort of Norwegian women. Also, plasma concentrations of hexachlorobenzene and PCBs were also associated with incidences of type 2 diabetes in a Nurses’ Health Study conducted in Massachusetts (127), (128).

From a mechanistic standpoint, it has been proposed that women may be more susceptible to diabetes than men due to their higher estrogen levels (120). POPs can induce cytochrome P450s such as CYP1A1/CYP1B1 which could catalyze the hydroxylation of the estradiol A ring, resulting in the generation of free radicals and reactive oxygen species. Reactive free radicals eventually induce oxidative stress which is often associated with pathologies such as diabetes and liver injury. It has also been hypothesized that dioxin-like POPs may act through the estrogen-dependent PPAR pathway to upregulate insulin-like growth factor binding protein-1 which counters the effects of insulin and aggravate diabetes (129). In addition, it appears that POPs, especially dioxins and PCBs, directly target the pancreas and affect pancreatic beta cell function thereby hampering insulin secretion, consequently leading to glucose intolerance and hyperglycemia (52). Therefore, looking at pancreatic vulnerability in women could be another important aspect to further explore the effects of POPs on diabetes.

In terms of obesogenic effects, a study conducted in Belgium in an adult population of both men and women demonstrated that high serum levels of hexachlorocyclohexane were positively correlated with increased body mass index and abdominal adiposity while serum PCB levels showed an inversed correlation with body mass index (130). Moreover, as observed in an elderly population in Uppsala, the lower chlorinated PCBs were associated with the existence or development of abdominal adiposity while the high molecular weight congeners that are heavily chlorinated appeared to have the opposite effect (131). Importantly, this observation suggests that the lower molecular weight PCB congeners that are broadly dioxin-like elicit an effect that is different from the heavily chlorinated congeners that are mostly non-dioxin like. Interestingly, the same study also reported that low-dose exposures to DDE and dioxins were also associated with abdominal adiposity. A cross-sectional study in postmenopausal, non-diabetic, obese women showed that women with higher plasma concentrations of POPs appeared to have decreased insulin sensitivity while obese women with better cardio-metabolic profiles had lower plasma POPs concentrations, implicating the ability of POPs to disrupt energy homeostasis in women (132). Effects of POPs on obesity appeared to be gender-based as evident from a children cohort study in the Faroes Island where girls tended to be more obese with prenatal PCB exposures compared to boys (133).

Epidemiologic studies shown strong associations between POPs especially dioxins and PCBs with liver diseases, including elevated liver enzymes and non-alcoholic fatty liver diseases encompassing steatosis and steatohepatitis (52), (134). However, hepato-toxicology is yet another area where gender or sex-based differences have not been widely acknowledged. Only a handful of studies are available for POPs and women’s hepatic health, including one cross-sectional study investigating sex-based associations for POPs (BDEs, OCPs and PCBs) and non-alcoholic fatty liver disease in patients who had undergone bariatric surgery that reported adverse associations between POPs and liver enzymes only among women (135). The liver is a sexually dimorphic organ, and it has been established that the cytochrome P450 genes are expressed in the liver in a sexually-biased pattern (136), (137). Because men and women may exhibit major differences in terms of POPs metabolism, as well as responses to lipid carbohydrate and bile acid metabolism, it is clear that more gender-based studies are needed, including in-depth women’s cohort studies that address the effects of pollutants on the liver, which not only regulates energy metabolism but also xenobiotic detoxification.`

Effects of POPs on reproductive health

POPs affect sexual function and fertility in adults, as well as developmental toxicity in offspring. Exposure to POPs affect fertility and reproductive health in both men and women; however, this section will address reproductive toxicity observed in women only. Preliminary studies investigating the effects of POPs in the context of female reproductive health began about two decades ago when exposure assessments were carried out in pregnant women (138), (139). Importantly dioxins, PCBs, some OCPs, PFCs and BDEs are all categorized as EDCs because of their interference on hormonal activities. Being EDCs, these POPs can dictate the onset of menarche and menopause in women, hence influencing the quality of life including reproductive development, duration of fertility period, risk for osteoporosis and cardiovascular diseases. A cross-sectional analysis employing the NHANES data from 1999 to 2008 demonstrated a clinically relevant association between levels of persistent EDCs comprising of PCBs [74, 99, 105, 118, 138, 153, 156, 170, 183], pesticides (DDE, hexachlorocyclohexane, Mirex), phthalates and a furan with early age at menopause in a large representative sample of women in the US (140). Evidence from the study suggested that increasing exposures to these chemicals adversely affected ovarian function especially as PCBs can bio-accumulate in the ovarian follicular wall, therefore, slowly damaging the follicular pool leading to early menopause. A setback of menopause is the reduction in estrogen levels, making women more vulnerable to osteoporosis, and some dioxin-like PCBs have been found to exacerbate bone weakness in postmenopausal women (141). In terms of menarche, a study analyzing multi-chemical exposure in Akwesasne Mohawk girls suggested that estrogenic PCB congeners affected the odds of reaching menarche and additional cohort studies performed in North Carolina and Chukotka (Russia), implicated that increased PCB levels among girls were associated with younger ages of attaining menarche and early sexual maturation (142), (143), (144). Furthermore, in Greenlandic women, age at menarche has diminished by 3 years as compared to a 100 years ago, which is an important factor to consider given that early menarche increases the risk for breast cancer (77). Interestingly, a study assessing in utero and postnatal exposure to polybrominated biphenyls also associated increased exposures with early age at menarche (145). However, when investigating the historical Seveso women cohort, there was no clear evidence that TCDD affected ovarian function in this population (146), while Han women from Northern China showed an association between PCBs, DDE and PAHs with polycystic ovary syndrome (147). Besides, multiple animal studies have shown many POPs that are EDCs affecting ovarian structure and function, and therefore environmental pollutant exposures should be considered important determinants when making fertility assessments (148).

Exposure to POPs is also unfavorable to fetal growth and development bearing in mind the inept metabolism, organ development and rapid growth during this stage (149), (150). Outcomes from in utero and prenatal exposures to POPs have been of interest since the 1980s with the notion that these exposures impact both intermediate birth outcomes and future life events and adult health. Several studies reported impaired fetal growth, reduced birth weight and lower head circumference with low levels of PCBs in mothers while other studies found inconsistent findings (151), (152), (153), (154). Because PCB congeners can be estrogenic or anti-estrogenic in nature which can influence birth outcomes, and because time of exposure can also affect developmental growth, these conflicting findings may be a reflection of differences in PCB congener composition and time of exposure (155). Another argument proposed was that certain study populations consumed high amounts of fish and high intakes of fish oil could improve placental blood flow which could result in heavier birth weights (156). Maternal serum and cord blood levels of DDT and DDE have also been linked to preterm birth, reduced birth weight, smaller head circumference at birth and incidences of spontaneous abortions (154), (157159). Similar observations related to reduced birth weight were seen with maternal serum and cord blood for PFOA and PFOS (160), (161), (162) and PBDEs (163), (164); while conflicting findings were found for hexachlorobenzene (165), (166), (167). Some studies suggested that the reduced birth weight could be due to increase in maternal gestation weight gain, although the relationship is more complex (150). Low birth weight of Vietnamese infants have also been related to high levels of TCDD and dioxin congeners in the mothers while maternal blood levels of PCDDs, PCDFs and PCBs were associated with lower birth weight in the Yusho cohort (168), (169). Also, the Yu-cheng women who were accidentally exposed to PCBs and PCDFs were reported to have higher rates of delivering a stillborn baby compared to the reference control population (170).

Differences in gender ratio at birth were not observed in this cohort although Yu-cheng men were found to have fewer male offspring compared to the reference control (171), (172). However, exposure to POPs can alter maternal hormone levels, which could potentially regulate the offspring sex. For example, trans-chlordane, DDT, DDE, PCB138 and PCB158 were speculated to behave as testosterone triggers which led to more baby boys, while PCB180 and hexachlorohexane have the opposite effect (31). Pregnant women who consumed maternal diets rich in dioxin-like compounds such as dioxin-like PCBs were reported to deliver babies with lower birth weight while increased fatty fish consumption during pregnancy have been associated with fetal growth retardation, raising concerns on necessary dietary guidelines for women of reproductive age (173), (174), (175). Background exposures to POPs have also been implicated in disrupting TH balance among pregnant women in Korean and Norwegian women; and altered maternal thyroid homeostasis could consequently affect fetal development (176), (177). Serum concentrations of POPs have also been associated with risk of developing pre-eclampsia, another pregnancy complication while ongoing exposures to POPs can also hamper the success of in vitro fertilization (178), (179).

There is a growing area of interest to investigate sex-based differences and birth outcomes such as fetal length and ponderal index from prenatal exposures to POPs. Some studies have shown that reduced fetal growth associated with prenatal exposures to mixtures of PCBs, PBDEs and DDT or PCBs and DDE were more pronounced in girls while the opposite effect was seen for hexachlorobenzene (180), (181), (182). However, another study looking at only PCBs reported that maternal-mediated PCB exposure was detrimental to fetal growth significantly in boys, but not in girls (152). These differences in findings reiterate the significance of looking at behaviors of mixtures rather than a single class of compounds. Additionally, data from an international general population study demonstrated that in utero exposure to dioxin-like compounds led to a shorter gestational age, particularly for boys (183) while a recent study from a prospective birth cohort in Japan concluded that prenatal exposures to OCPs disrupted reproductive hormones of the fetus in utero significantly for boys (184).

Transgenerational exposures to POPs

Adverse health effects that develop in children as a result of prior chemical exposures by previous generations including their parents and grandparents are deemed transgenerational effects, and such exposures are considered transgenerational exposures. Transgenerational effects are commonly understood to be due to transmission of information from the parent to the child that affects the child’s traits or phenotype without altering the primary DNA structure or nucleotide sequence; in other words, epigenetic inheritance. Implications of transgenerational exposures reviewed in this section are associated with maternal exposures and hence, are impactful to the said mother and such effects can also be broadly categorized as consequences of maternal exposures.

Serial studies conducted on the offspring of Yu-cheng women reported that the children of highly-exposed PCBs/PCDFs mothers showed signs of cognitive deficits and impaired neonatal dental developmental, apart from retarded growth at birth (185), (186). These Yu-cheng children, born between 1978 and 1992, underwent extensive neurological examinations and displayed delayed cognitive processing as well as attention deficits and behavioral problems (186). Furthermore, Yu-cheng children suffered from hyperpigmentation, nail deformities, acne scars, hair loss and were more susceptible to inflammatory diseases (185), (187), (188). Susceptibility to infections and immunomodulation was also reported in Inuit infants while a long-term Dutch cohort study demonstrated that prenatal exposures to PCBs and dioxins induced immunologic changes that persisted into adulthood (189), (190).

Other birth cohort studies in Europe have demonstrated negative associations between prenatal PCB and dioxin exposures and psychomotor and neurologic development in children (191), (192). In contrast, a large, multi-center study conducted in the US observed variable results when studying associations between low levels of prenatal PCB exposure and cognitive/motor development of 8-month-old infants while 4-year-old children whose mothers consumed sports fish from the Great Lakes and therefore have higher levels of PCBs, exhibited poor neurological development, suggesting that such effects may be subjected to dose and duration of exposure (193), (194). A study conducted in a Spanish birth cohort found positive associations between concentrations of PBDEs in breast milk and impaired neuropsychological development in infants 12–18 months of age (195). Also, in utero exposure to DDT and DDE was associated with delayed neurodevelopment in Mexican-American children (196). While some studies projected that these neuropsychological and cognitive effects of POPs may not impact adulthood as observed in a long-term study that followed-up beyond childhood (197); other studies have suggested that in utero exposure to POPs like PCBs can have long-term impact on intellectual function (198). Nonetheless, it is pertinent to say that exposures to POPs such as PCBs, dioxins and DDT at levels that are higher than the average exposure levels of the general population may possibly have long-term impact on cognitive function in children (199), (200). Likewise, effects of POPs in children appeared to be associated with chronic obstructive lung diseases that persisted way into adulthood (201). A compelling observation was that Yu-cheng boys also exhibited alterations in sex hormones such as higher serum estradiol and lower testosterone levels when mothers had higher levels of PCBs/PCDFs while a follow-up analysis on boys who participated in the North Carolina Infant Study demonstrated that higher prenatal exposures to DDE was associated with increased height and weight gain at puberty (202), (203). These gender-based effects in children may be attributed to the estrogenic and anti-androgenic of some of these POPs such as DDE which can greatly sway endocrine physiology and homeostasis (204).

Other diseases

Other disease types that can result from exposures to POPs include cognitive impairment, neurological disorders, nephrotoxicity, respiratory problems and thyroid disorders among others. With regard to women’s health, acute and accidental exposures to POPs have been much more extensively studied; however, disorders arising from chronic exposures have been more male-oriented. In fact the literature is scarce in the context of subtle disorders associated with chronic and low-dose exposure to environmental chemicals in women with only a handful of studies published to date (68), (205), (206). This apparent gap in knowledge necessitates investigations for such disorders employing epidemiologic and animal studies to accurately address sex-based differences associated with chronic exposures. Nonetheless, the amount of evidence available so far clearly portrays the causal effects of POPs in disorders exclusive to women’s health such as breast cancer and heavily impact other health disorders that may not necessarily be gender-based. A schematic diagram demonstrating main biological receptors and proteins that are targeted by POPs described in this review and the health consequences that arise from various chemical-receptor interactions is shown in Figure 1.

A schematic presentation of the main biological receptors activated by POPs and some of the consequent pathological responses and diseases reported in women. Illustrations of organs (liver and reproductive system) were obtained from https://reactome.org (207).
Figure 1:

A schematic presentation of the main biological receptors activated by POPs and some of the consequent pathological responses and diseases reported in women. Illustrations of organs (liver and reproductive system) were obtained from https://reactome.org (207).

Conclusion

The current review addressed certain health impacts of environmental chemical exposures in women based on available epidemiologic findings and stressed on the importance of acknowledging gene-environment interactions in women’s health. It also noted the insufficiency of studies pertaining to gender-based exposure research (based on gender identity of the subject) and studies on sex-related differences and similarities (based on biological sex differences), albeit incredibly progressive findings and research advancement in the field of environmental health. The review also highlighted the need for more guidelines on dietary patterns and information on exposure history for women of reproductive age and pregnant women alike, considering that current levels of POPs in women can also affect future generations. Moreover, although women population studies such as the Greenlandic Inuit, Yusho, Yu-cheng and Seveso cohorts have been acknowledged and are still undergoing research investigations, occupational cohorts of highly exposed women world-wide including women working in electrical-manufacturing plants and female pesticide applicators are in dire need to further investigate disease susceptibility and progression. Additionally, existence of sex-gene interactions has already been established, especially for vital organs such as the liver, and these interactions are of significance when exploring pathological mechanisms and designing drug therapy. Therefore, emphasis on sex–gene interactions in environmental health can also provide valuable data to further understand how environmental exposures can result in certain outcomes such as the observable feminization of male organs (208). Furthermore, research studies on genotype-environment and environment-environment interactions have garnered a much bigger audience in the past decade or so with increased communal environmental awareness and public health consciousness. To conclude, assessing gender-sensitive and sex-based differences in POPs exposures can provide a distinct socio-cultural perspective to environmental pollutant exposure studies, otherwise restricted to health outcomes only; and can be of paramount value in environmental health as this will allow researchers to better identify and ascertain the affected or vulnerable populations.

Acknowledgments

The author would like to acknowledge the University of Louisville, Division of Gastroenterology, Hepatology and Nutrition, and Dr. Matthew Cave’s laboratory group, for moral support.

References

  • 1.

    Nunes LM, Robles-Escajeda E, Santiago-Vazquez Y, Ortega NM, Lema C, Muro A et al. The gender of cell lines matters when screening for novel anti-cancer drugs. AAPS J 2014;16(4):872–4. CrossrefPubMedGoogle Scholar

  • 2.

    Spoletini I, Vitale C, Malorni W, Rosano GM. Sex differences in drug effects: interaction with sex hormones in adult life. Handb Exp Pharmacol 2012;(214):91–105. Google Scholar

  • 3.

    Ritter L, Solomon KR, Forget J, Stemeroff M, O’Leary C. Persistent organic pollutants: an assessment report on DDT, aldrin, dieldrin, endrin, chlordane, heptachlor, hexachlorobenzene, mirex, toxaphene, polychlorinated biphenyls, dioxins, and furans. International Programme on Chemical Safety (IPCS). 1995. Google Scholar

  • 4.

    El-Shahawi MS, Hamza A, Bashammakh AS, Al-Saggaf WT. An overview on the accumulation, distribution, transformations, toxicity and analytical methods for the monitoring of persistent organic pollutants. Talanta 2010;80(5):1587–97. CrossrefPubMedGoogle Scholar

  • 5.

    Vallack HW, Bakker DJ, Brandt I, Brostrom-Lunden E, Brouwer A, Bull KR, et al. Controlling persistent organic pollutants-what next? Environ Toxicol Pharmacol 1998;6(3):143–75. PubMedCrossrefGoogle Scholar

  • 6.

    Porta M, Zumeta E. Implementing the Stockholm treaty on persistent organic pollutants. Occup Environ Med 2002;59(10):651–2. PubMedCrossrefGoogle Scholar

  • 7.

    Karlaganis G, Marioni R, Sieber I, Weber A. The elaboration of the ‘Stockholm convention’ on persistent organic pollutants (POPs): a negotiation process fraught with obstacles and opportunities. Environ Sci Pollut Res Int 2001;8(3):216–21. PubMedCrossrefGoogle Scholar

  • 8.

    Warmuth A, Ohno K. The PCBs elimination network: the information exchange platform created for the risk reduction of polychlorinated biphenyls (PCBs). J Epidemiol Community Health 2013;67(1):4–5. CrossrefGoogle Scholar

  • 9.

    Jennings AA, Li Z. Residential surface soil guidance applied worldwide to the pesticides added to the Stockholm Convention in 2009 and 2011. J Environ Manage 2015;160:226–40. PubMedCrossrefGoogle Scholar

  • 10.

    Wohrnschimmel H, Scheringer M, Bogdal C, Hung H, Salamova A, Venier M, et al. Ten years after entry into force of the Stockholm Convention: what do air monitoring data tell about its effectiveness? Environ Pollut 2016;217:149–58. CrossrefPubMedGoogle Scholar

  • 11.

    International POPs Elimination Network. At UN chemicals meeting, political will clashes with narrow commercial interests. Press Release. http://www.ipen.org/conferences/cop8, 5 May 2017. 

  • 12.

    Schecter A, Birnbaum L, Ryan JJ, Constable JD. Dioxins: an overview. Environ Res 2006;101(3):419–28. CrossrefPubMedGoogle Scholar

  • 13.

    Stieger G, Scheringer M, Ng CA, Hungerbuhler K. Assessing the persistence, bioaccumulation potential and toxicity of brominated flame retardants: data availability and quality for 36 alternative brominated flame retardants. Chemosphere 2014;116:118–23. PubMedCrossrefGoogle Scholar

  • 14.

    Birnbaum LS, Staskal DF. Brominated flame retardants: cause for concern? Environ Health Perspect 2004;112(1):9–17. CrossrefPubMedGoogle Scholar

  • 15.

    Kim YR, Harden FA, Toms LM, Norman RE. Health consequences of exposure to brominated flame retardants: a systematic review. Chemosphere 2014;106:1–19. PubMedCrossrefGoogle Scholar

  • 16.

    Fiedler H. Dioxins and Furans (PCDD/PCDF). In: Persistent Organic Pollutants. Edited by Fiedler H. Berlin, Heidelberg: Springer Berlin Heidelberg; 2003:123–201. Google Scholar

  • 17.

    Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 2007;99(2):366–94. PubMedCrossrefGoogle Scholar

  • 18.

    Steenland K, Fletcher T, Savitz DA. Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ Health Perspect 2010;118(8):1100–8. CrossrefPubMedGoogle Scholar

  • 19.

    Kuratsune M, Yoshimura T, Matsuzaka J, Yamaguchi A. Yusho, a poisoning caused by rice oil contaminated with polychlorinated biphenyls. HSMHA Health Rep 1971;86(12):1083–91. CrossrefPubMedGoogle Scholar

  • 20.

    Kuratsune M, Yoshimura T, Matsuzaka J, Yamaguchi A. Epidemiologic study on Yusho, a poisoning caused by ingestion of rice oil contaminated with a commercial brand of polychlorinated biphenyls. Environ Health Perspect 1972;1:119–28. CrossrefPubMedGoogle Scholar

  • 21.

    Masuda Y, Kuroki H, Haraguchi K, Nagayama J. PCB and PCDF congeners in the blood and tissues of yusho and yu-cheng patients. Environ Health Perspect 1985;59:53–8. PubMedGoogle Scholar

  • 22.

    Hsu ST, Ma CI, Hsu SK, Wu SS, Hsu NH, Yeh CC, et al. Discovery and epidemiology of PCB poisoning in Taiwan: a four-year followup. Environ Health Perspect 1985;59:5–10. PubMedGoogle Scholar

  • 23.

    Loomis D, Browning SR, Schenck AP, Gregory E, Savitz DA. Cancer mortality among electric utility workers exposed to polychlorinated biphenyls. Occup Environ Med 1997;54(10):720–8. CrossrefPubMedGoogle Scholar

  • 24.

    Kreiss K. Studies on populations exposed to polychlorinated biphenyls. Environ Health Perspect 1985;60:193–9. CrossrefPubMedGoogle Scholar

  • 25.

    Ruder AM, Hein MJ, Hopf NB, Waters MA. Mortality among 24,865 workers exposed to polychlorinated biphenyls (PCBs) in three electrical capacitor manufacturing plants: a ten-year update. Int J Hyg Environ Health 2014;217(2-3):176–87. CrossrefPubMedGoogle Scholar

  • 26.

    Sinks T, Steele G, Smith AB, Watkins K, Shults RA. Mortality among workers exposed to polychlorinated biphenyls. Am J Epidemiol 1992;136(4):389–98. CrossrefPubMedGoogle Scholar

  • 27.

    Centers for Disease C: Preliminary report: 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure to humans – Seveso, Italy. MMWR Morb Mortal Wkly Rep 1988;37(48):7336. Google Scholar

  • 28.

    Yi SW, Ryu SY, Ohrr H, Hong JS. Agent Orange exposure and risk of death in Korean Vietnam veterans: Korean Veterans Health Study. Int J Epidemiol 2014;43(6):1825–34. CrossrefPubMedGoogle Scholar

  • 29.

    Dudarev AA. Dietary exposure to persistent organic pollutants and metals among Inuit and Chukchi in Russian Arctic Chukotka. Int J Circumpolar Health 2012;71:18592. CrossrefGoogle Scholar

  • 30.

    Azlan A, Nasir NN, Shamsudin N, Rahman HA, Khoo HE, Razman MR. PCDD and PCDF exposures among fishing community through intake of fish and shellfish from the Straits of Malacca. BMC Public Health 2015;15:683. CrossrefPubMedGoogle Scholar

  • 31.

    Tan J, Loganath A, Chong YS, Obbard JP. Exposure to persistent organic pollutants in utero and related maternal characteristics on birth outcomes: a multivariate data analysis approach. Chemosphere 2009;74(3):428–33. CrossrefPubMedGoogle Scholar

  • 32.

    Haddad S, Ayotte P, Verner MA. Derivation of exposure factors for infant lactational exposure to persistent organic pollutants (POPs). Regul Toxicol Pharmacol 2015;71(2):135–40. PubMedCrossrefGoogle Scholar

  • 33.

    Fernandez-Rodriguez M, Arrebola JP, Artacho-Cordon F, Amaya E, Aragones N, Llorca J, et al. Levels and predictors of persistent organic pollutants in an adult population from four Spanish regions. Sci Total Environ 2015;538:152–61. CrossrefGoogle Scholar

  • 34.

    Carpenter DO. Health effects of persistent organic pollutants: the challenge for the Pacific Basin and for the world. Rev Environ Health 2011;26(1):61–9. PubMedGoogle Scholar

  • 35.

    Pesatori AC, Grillo P, Consonni D, Caironi M, Sampietro G, Olivari L, et al. Update of the mortality study of workers exposed to polychlorinated biphenyls (Pcbs) in two Italian capacitor manufacturing plants. Med Lav 2013;104(2):107–14. PubMedGoogle Scholar

  • 36.

    Collins JJ, Bodner KM, Aylward LL, Bender TJ, Anteau S, Wilken M, et al. Mortality risk among workers with exposure to dioxins. Occup Med (Lond) 2016;66(9):706–12. PubMedCrossrefGoogle Scholar

  • 37.

    Ren A, Qiu X, Jin L, Ma J, Li Z, Zhang L, et al. Association of selected persistent organic pollutants in the placenta with the risk of neural tube defects. Proc Natl Acad Sci U S A 2011;108(31):12770–5. CrossrefPubMedGoogle Scholar

  • 38.

    Ruzzin J. Public health concern behind the exposure to persistent organic pollutants and the risk of metabolic diseases. BMC Public Health 2012;12:298. CrossrefPubMedGoogle Scholar

  • 39.

    Lee DH, Lind PM, Jacobs Jr. DR, Salihovic S, van Bavel B, Lind L. Background exposure to persistent organic pollutants predicts stroke in the elderly. Environ Int 2012;47:115–20. CrossrefPubMedGoogle Scholar

  • 40.

    Sorg O. AhR signalling and dioxin toxicity. Toxicol Lett 2014;230(2):225–33. PubMedCrossrefGoogle Scholar

  • 41.

    Beischlag TV, Luis Morales J, Hollingshead BD, Perdew GH. The aryl hydrocarbon receptor complex and the control of gene expression. Crit Rev Eukaryot Gene Expr 2008;18(3): 207–50. PubMedCrossrefGoogle Scholar

  • 42.

    Lindsey S, Papoutsakis ET. The evolving role of the aryl hydrocarbon receptor (AHR) in the normophysiology of hematopoiesis. Stem Cell Rev 2012;8(4):1223–35. PubMedCrossrefGoogle Scholar

  • 43.

    Romkes M, Piskorska-Pliszczynska J, Safe S. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on hepatic and uterine estrogen receptor levels in rats. Toxicol Appl Pharmacol 1987;87(2):306–14. CrossrefPubMedGoogle Scholar

  • 44.

    Wang L, He X, Szklarz GD, Bi Y, Rojanasakul Y, Ma Q. The aryl hydrocarbon receptor interacts with nuclear factor erythroid 2-related factor 2 to mediate induction of NAD(P)H:quinoneoxidoreductase 1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch Biochem Biophys 2013;537(1):31–8.CrossrefGoogle Scholar

  • 45.

    McLean LS, Watkins CN, Campbell P, Zylstra D, Rowland L, Amis LH, et al. Aryl hydrocarbon receptor ligand 5F 203 induces oxidative stress that triggers DNA damage in human breast cancer cells. Chem Res Toxicol 2015;28(5):855–71. PubMedCrossrefGoogle Scholar

  • 46.

    Wahlang B, Falkner KC, Clair HB, Al-Eryani L, Prough RA, States JC, et al. Human receptor activation by aroclor 1260, a polychlorinated biphenyl mixture. Toxicol Sci 2014;140(2):283–97. PubMedCrossrefGoogle Scholar

  • 47.

    Al-Salman F, Plant N. Non-coplanar polychlorinated biphenyls (PCBs) are direct agonists for the human pregnane-X receptor and constitutive androstane receptor, and activate target gene expression in a tissue-specific manner. Toxicol Appl Pharmacol 2012;263(1):7–13. CrossrefGoogle Scholar

  • 48.

    Chen CL, Brodie AE, Hu CY. CCAAT/enhancer-binding protein beta is not affected by tetrachlorodibenzo-p-dioxin (TCDD) inhibition of 3T3-L1 preadipocyte differentiation. Obes Res 1997;5(2):146–52. CrossrefPubMedGoogle Scholar

  • 49.

    Zhang L, Nichols RG, Correll J, Murray IA, Tanaka N, Smith PB et al. Persistent organic pollutants modify gut microbiota-host metabolic homeostasis in mice through aryl hydrocarbon receptor activation. Environ Health Perspect 2015;123(7):679–88. CrossrefPubMedGoogle Scholar

  • 50.

    Ambolet-Camoit A, Ottolenghi C, Leblanc A, Kim MJ, Letourneur F, Jacques S, et al. Two persistent organic pollutants which act through different xenosensors (alpha-endosulfan and 2,3,7,8 tetrachlorodibenzo-p-dioxin) interact in a mixture and downregulate multiple genes involved in human hepatocyte lipid and glucose metabolism. Biochimie 2015;116:79–91. CrossrefGoogle Scholar

  • 51.

    Lee J, Scheri RC, Zhang Y, Curtis LR. Chlordecone, a mixed pregnane X receptor (PXR) and estrogen receptor alpha (ERalpha) agonist, alters cholesterol homeostasis and lipoprotein metabolism in C57BL/6 mice. Toxicol Appl Pharmacol 2008;233(2):193–202. CrossrefPubMedGoogle Scholar

  • 52.

    Heindel JJ, Blumberg B, Cave M, Machtinger R, Mantovani A, Mendez MA, et al. Metabolism disrupting chemicals and metabolic disorders. Reprod Toxicol 2017;68:3–33. CrossrefPubMedGoogle Scholar

  • 53.

    Aoki Y. Polychlorinated biphenyls, polychlorinated dibenzo-p-dioxins, and polychlorinated dibenzofurans as endocrine disrupters – what we have learned from Yusho disease. Environ Res 2001;86(1):2–11. CrossrefPubMedGoogle Scholar

  • 54.

    De Coster S, van Larebeke N. Endocrine-disrupting chemicals: associated disorders and mechanisms of action. J Environ Public Health 2012;2012:713696. PubMedGoogle Scholar

  • 55.

    Boverhof DR, Kwekel JC, Humes DG, Burgoon LD, Zacharewski TR. Dioxin induces an estrogen-like, estrogen receptor-dependent gene expression response in the murine uterus. Mol Pharmacol 2006;69(5):1599–606. PubMedCrossrefGoogle Scholar

  • 56.

    Liu D, Perkins JT, Petriello MC, Hennig B. Exposure to coplanar PCBs induces endothelial cell inflammation through epigenetic regulation of NF-kappaB subunit p65. Toxicol Appl Pharmacol 2015;289(3):457–65. CrossrefPubMedGoogle Scholar

  • 57.

    Casati L, Sendra R, Poletti A, Negri-Cesi P, Celotti F. Androgen receptor activation by polychlorinated biphenyls: epigenetic effects mediated by the histone demethylase Jarid1b. Epigenetics 2013;8(10):1061–8. CrossrefPubMedGoogle Scholar

  • 58.

    Collotta M, Bertazzi PA, Bollati V. Epigenetics and pesticides. Toxicology 2013;307:35–41. CrossrefPubMedGoogle Scholar

  • 59.

    Wahlang B, Petriello MC, Perkins JT, Shen S, Hennig B. Polychlorinated biphenyl exposure alters the expression profile of microRNAs associated with vascular diseases. Toxicol In Vitro 2016;35:180–7. CrossrefPubMedGoogle Scholar

  • 60.

    Krauskopf J, de Kok TM, Hebels DG, Bergdahl IA, Johansson A, Spaeth F, et al. MicroRNA profile for health risk assessment: environmental exposure to persistent organic pollutants strongly affects the human blood microRNA machinery. Sci Rep 2017;7(1):9262. PubMedCrossrefGoogle Scholar

  • 61.

    Hardesty JE, Al-Eryani L, Wahlang B, Falkner KC, Shi H, Jin J, et al. Epidermal growth factor receptor signaling disruption by endocrine and metabolic disrupting chemicals. Toxicol Sci 2018;162(2):622–34. PubMedCrossrefGoogle Scholar

  • 62.

    Luthe G, Jacobus JA, Robertson LW. Receptor interactions by polybrominated diphenyl ethers versus polychlorinated biphenyls: a theoretical structure-activity assessment. Environ Toxicol. Pharmacol. 2008;25(2):202–10. PubMedCrossrefGoogle Scholar

  • 63.

    Lesiak A, Zhu M, Chen H, Appleyard SM, Impey S, Lein PJ, et al. The environmental neurotoxicant PCB 95 promotes synaptogenesis via ryanodine receptor-dependent miR132 upregulation. J Neurosci 2014;34(3):717–25. PubMedCrossrefGoogle Scholar

  • 64.

    De Tata V. Association of dioxin and other persistent organic pollutants (POPs) with diabetes: epidemiological evidence and new mechanisms of beta cell dysfunction. Int J Mol Sci 2014;15(5):7787–811. CrossrefPubMedGoogle Scholar

  • 65.

    Qian Y, Ducatman A, Ward R, Leonard S, Bukowski V, Lan Guo N, et al. Perfluorooctane sulfonate (PFOS) induces reactive oxygen species (ROS) production in human microvascular endothelial cells: role in endothelial permeability. J Toxicol Environ Health A 2010;73(12):819–36. CrossrefPubMedGoogle Scholar

  • 66.

    Majkova Z, Toborek M, Hennig B. The role of caveolae in endothelial cell dysfunction with a focus on nutrition and environmental toxicants. J Cell Mol Med 2010;14(10):2359–70. CrossrefPubMedGoogle Scholar

  • 67.

    Fantini F, Porta D, Fano V, De Felip E, Senofonte O, Abballe A, et al. Epidemiologic studies on the health status of the population living in the Sacco River Valley. Epidemiol Prev 2012;36(5 Suppl 4):44–52. PubMedGoogle Scholar

  • 68.

    Lee DH, Lind PM, Jacobs Jr. DR, Salihovic S, van Bavel B, Lind L. Association between background exposure to organochlorine pesticides and the risk of cognitive impairment: a prospective study that accounts for weight change. Environ Int 2016;89–90:179–84. PubMedGoogle Scholar

  • 69.

    Rubin CH, Lanier A, Kieszak S, Brock JW, Koller KR, Strosnider H, et al. Breast cancer among Alaska Native women potentially exposed to environmental organochlorine chemicals. Int J Circumpolar Health 2006;65(1):18–27. PubMedCrossrefGoogle Scholar

  • 70.

    Pavuk M, Cerhan JR, Lynch CF, Kocan A, Petrik J, Chovancova J. Case-control study of PCBs, other organochlorines and breast cancer in Eastern Slovakia. J Expo Anal Environ Epidemiol 2003;13(4):267–75. PubMedCrossrefGoogle Scholar

  • 71.

    Hurley S, Reynolds P, Goldberg D, Nelson DO, Jeffrey SS, Petreas M. Adipose levels of polybrominated diphenyl ethers and risk of breast cancer. Breast Cancer Res Treat 2011;129(2):505–11. CrossrefPubMedGoogle Scholar

  • 72.

    Stelzer A, Chan HM. The relative estrogenic activity of technical toxaphene mixture and two individual congeners. Toxicology 1999;138(2):69–80. CrossrefPubMedGoogle Scholar

  • 73.

    Saleh MA. Toxaphene: chemistry, biochemistry, toxicity and environmental fate. Rev Environ Contam Toxicol 1991;118:1–85. PubMedGoogle Scholar

  • 74.

    Soto AM, Chung KL, Sonnenschein C. The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells. Environ Health Perspect 1994;102(4):380–3. CrossrefPubMedGoogle Scholar

  • 75.

    Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37(Suppl 8):S4–66. PubMedCrossrefGoogle Scholar

  • 76.

    Bonefeld-Jorgensen EC, Long M, Bossi R, Ayotte P, Asmund G, Kruger T, et al. Perfluorinated compounds are related to breast cancer risk in Greenlandic Inuit: a case control study. Environ Health 2011;10:88. CrossrefPubMedGoogle Scholar

  • 77.

    Fredslund SO, Bonefeld-Jorgensen EC. Breast cancer in the Arctic – changes over the past decades. Int J Circumpolar Health 2012;71:19155. CrossrefGoogle Scholar

  • 78.

    Wielsoe M, Kern P, Bonefeld-Jorgensen EC. Serum levels of environmental pollutants is a risk factor for breast cancer in Inuit: a case control study. Environ Health 2017;16(1):56. PubMedCrossrefGoogle Scholar

  • 79.

    Bonefeld-Jorgensen EC. Biomonitoring in Greenland: human biomarkers of exposure and effects – a short review. Rural Remote Health 2010;10(2):1362. Google Scholar

  • 80.

    Harboe TL, Eiberg H, Kern P, Ejlertsen B, Nedergaard L, Timmermans-Wielenga V, et al. A high frequent BRCA1 founder mutation identified in the Greenlandic population. Fam Cancer 2009;8(4):413–9. CrossrefPubMedGoogle Scholar

  • 81.

    Ghisari M, Eiberg H, Long M, Bonefeld-Jorgensen EC. Polymorphisms in phase I and phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case-control study in Inuit women. Environ Health 2014;13(1):19. PubMedCrossrefGoogle Scholar

  • 82.

    Mathur V, Bhatnagar P, Sharma RG, Acharya V, Sexana R. Breast cancer incidence and exposure to pesticides among women originating from Jaipur. Environ Int 2002;28(5):331–6. CrossrefPubMedGoogle Scholar

  • 83.

    Holmes AK, Koller KR, Kieszak SM, Sjodin A, Calafat AM, Sacco FD, et al. Case-control study of breast cancer and exposure to synthetic environmental chemicals among Alaska Native women. Int J Circumpolar Health 2014;73:25760. CrossrefGoogle Scholar

  • 84.

    Arrebola JP, Fernandez-Rodriguez M, Artacho-Cordon F, Garde C, Perez-Carrascosa F, Linares I, et al. Associations of persistent organic pollutants in serum and adipose tissue with breast cancer prognostic markers. Sci Total Environ 2016;566–567:41–9. PubMedGoogle Scholar

  • 85.

    Khanjani N, English DR, Sim MR. An ecological study of organochlorine pesticides and breast cancer in rural Victoria, Australia. Arch Environ Contam Toxicol 2006;50(3):452–61. PubMedCrossrefGoogle Scholar

  • 86.

    Waliszewski SM, Bermudez MT, Infanzon RM, Silva CS, Carvajal O, Trujillo P, et al. Persistent organochlorine pesticide levels in breast adipose tissue in women with malignant and benign breast tumors. Bull Environ Contam Toxicol 2005;75(4):752–9. CrossrefPubMedGoogle Scholar

  • 87.

    Itoh H, Iwasaki M, Kasuga Y, Yokoyama S, Onuma H, Nishimura H, et al. Association between serum organochlorines and global methylation level of leukocyte DNA among Japanese women: a cross-sectional study. Sci Total Environ 2014;490:603–9. PubMedCrossrefGoogle Scholar

  • 88.

    Rusiecki JA, Baccarelli A, Bollati V, Tarantini L, Moore LE, Bonefeld-Jorgensen EC. Global DNA hypomethylation is associated with high serum-persistent organic pollutants in Greenlandic Inuit. Environ Health Perspect 2008;116(11):1547–52. PubMedCrossrefGoogle Scholar

  • 89.

    Hoyer AP, Gerdes AM, Jorgensen T, Rank F, Hartvig HB. Organochlorines, p53 mutations in relation to breast cancer risk and survival. A Danish cohort-nested case-controls study. Breast Cancer Res Treat 2002;71(1):59–65. CrossrefPubMedGoogle Scholar

  • 90.

    Lu X, Lessner L, Carpenter DO. Association between hospital discharge rate for female breast cancer and residence in a zip code containing hazardous waste sites. Environ Res 2014;134:375–81. CrossrefGoogle Scholar

  • 91.

    Lambertino A, Turyk M, Anderson H, Freels S, Persky V. Uterine leiomyomata in a cohort of Great Lakes sport fish consumers. Environ Res 2011;111(4):565–72. CrossrefGoogle Scholar

  • 92.

    Schaefer WR, Hermann T, Meinhold-Heerlein I, Deppert WR, Zahradnik HP. Exposure of human endometrium to environmental estrogens, antiandrogens, and organochlorine compounds. Fertil Steril 2000;74(3):558–63. CrossrefPubMedGoogle Scholar

  • 93.

    Trabert B, Chen Z, Kannan K, Peterson CM, Pollack AZ, Sun L, et al. Persistent organic pollutants (POPs) and fibroids: results from the ENDO study. J Expo Sci Environ Epidemiol 2015;25(3):278–5. CrossrefPubMedGoogle Scholar

  • 94.

    Polanco Rodriguez AG, Inmaculada Riba Lopez M, Angel DelValls Casillas T, Leon JA, Anjan Kumar Prusty B, Alvarez Cervera FJ. Levels of persistent organic pollutants in breast milk of Maya women in Yucatan, Mexico. Environ Monit Assess 2017;189(2):59. PubMedCrossrefGoogle Scholar

  • 95.

    Polanco Rodriguez AG, Riba Lopez MI, DelValls Casillas TA, Araujo Leon JA, Mahjoub O, Prusty AK. Monitoring of organochlorine pesticides in blood of women with uterine cervix cancer. Environ Pollut 2017;220(Pt B):853–62. CrossrefPubMedGoogle Scholar

  • 96.

    Weiderpass E, Adami HO, Baron JA, Wicklund-Glynn A, Aune M, Atuma S, et al. Organochlorines and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev 2000;9(5):487–93. PubMedGoogle Scholar

  • 97.

    Windham GC, Lee D, Mitchell P, Anderson M, Petreas M, Lasley B. Exposure to organochlorine compounds and effects on ovarian function. Epidemiology 2005;16(2):182–90. CrossrefPubMedGoogle Scholar

  • 98.

    Ploteau S, Cano-Sancho G, Volteau C, Legrand A, Venisseau A, Vacher V, et al. Associations between internal exposure levels of persistent organic pollutants in adipose tissue and deep infiltrating endometriosis with or without concurrent ovarian endometrioma. Environ Int 2017;108:195–203. CrossrefPubMedGoogle Scholar

  • 99.

    Donat-Vargas C, Akesson A, Berglund M, Glynn A, Wolk A, Kippler M. Dietary exposure to polychlorinated biphenyls and risk of breast, endometrial and ovarian cancer in a prospective cohort. Br J Cancer 2016;115(9):1113–21. CrossrefGoogle Scholar

  • 100.

    Warner M, Mocarelli P, Samuels S, Needham L, Brambilla P, Eskenazi B. Dioxin exposure and cancer risk in the Seveso Women’s Health Study. Environ Health Perspect 2011;119(12):1700–05. PubMedCrossrefGoogle Scholar

  • 101.

    Brustad M, Sandanger TM, Andersen V, Lund E. POP exposure from fish liver consumption and risk of cancer – the Norwegian Women and Cancer Study. J Environ Monit 2007;9(7):682–6. CrossrefPubMedGoogle Scholar

  • 102.

    VoPham T, Brooks MM, Yuan JM, Talbott EO, Ruddell D, Hart JE, et al. Pesticide exposure and hepatocellular carcinoma risk: a case-control study using a geographic information system (GIS) to link SEER-Medicare and California pesticide data. Environ Res 2015;143(Pt A):68–82. CrossrefGoogle Scholar

  • 103.

    Maas AH, Appelman YE. Gender differences in coronary heart disease. Neth Heart J 2010;18(12):598–602. CrossrefPubMedGoogle Scholar

  • 104.

    Towfighi A, Zheng L, Ovbiagele B. Sex-specific trends in midlife coronary heart disease risk and prevalence. Arch Intern Med 2009;169(19):1762–6. PubMedCrossrefGoogle Scholar

  • 105.

    Goncharov A, Bloom M, Pavuk M, Birman I, Carpenter DO. Blood pressure and hypertension in relation to levels of serum polychlorinated biphenyls in residents of Anniston, Alabama. J Hypertens 2010;28(10):2053–60. CrossrefPubMedGoogle Scholar

  • 106.

    Goncharov A, Pavuk M, Foushee HR, Carpenter DO, Anniston Environmental Health Reseach C. Blood pressure in relation to concentrations of PCB congeners and chlorinated pesticides. Environ Health Perspect 2011;119(3):319–25. CrossrefPubMedGoogle Scholar

  • 107.

    Valera B, Jorgensen ME, Jeppesen C, Bjerregaard P. Exposure to persistent organic pollutants and risk of hypertension among Inuit from Greenland. Environ Res 2013;122:65–73. PubMedCrossrefGoogle Scholar

  • 108.

    Everett CJ, Mainous 3rd AG, Frithsen IL, Player MS, Matheson EM. Association of polychlorinated biphenyls with hypertension in the 1999-2002 National Health and Nutrition Examination Survey. Environ Res 2008;108(1):94–7. CrossrefPubMedGoogle Scholar

  • 109.

    Lind PM, Penell J, Salihovic S, van Bavel B, Lind L. Circulating levels of p,p’-DDE are related to prevalent hypertension in the elderly. Environ Res 2014;129:27–31. CrossrefPubMedGoogle Scholar

  • 110.

    Pesatori AC, Zocchetti C, Guercilena S, Consonni D, Turrini D, Bertazzi PA. Dioxin exposure and non-malignant health effects: a mortality study. Occup Environ Med 1998;55(2):126–31. CrossrefPubMedGoogle Scholar

  • 111.

    Ha MH, Lee DH, Son HK, Park SK, Jacobs Jr. DR. Association between serum concentrations of persistent organic pollutants and prevalence of newly diagnosed hypertension: results from the National Health and Nutrition Examination Survey 1999–2002. J Hum Hypertens 2009;23(4):274–86. CrossrefPubMedGoogle Scholar

  • 112.

    Safe S, Wang F, Porter W, Duan R, McDougal A. Ah receptor agonists as endocrine disruptors: antiestrogenic activity and mechanisms. Toxicol Lett 1998;102–103:343–7. PubMedGoogle Scholar

  • 113.

    Lind PM, Salihovic S, van Bavel B, Lind L. Circulating levels of perfluoroalkyl substances (PFASs) and carotid artery atherosclerosis. Environ Res 2017;152:157–64. PubMedCrossrefGoogle Scholar

  • 114.

    Lin CY, Lin LY, Wen TW, Lien GW, Chien KL, Hsu SH, et al. Association between levels of serum perfluorooctane sulfate and carotid artery intima-media thickness in adolescents and young adults. Int J Cardiol 2013;168(4):3309–16. CrossrefGoogle Scholar

  • 115.

    Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120(16):1640–5. Google Scholar

  • 116.

    Bentley-Lewis R, Koruda K, Seely EW. The metabolic syndrome in women. Nat Clin Pract Endocrinol Metab 2007;3(10):696–704. PubMedCrossrefGoogle Scholar

  • 117.

    Fierens S, Mairesse H, Heilier JF, De Burbure C, Focant JF, Eppe G, et al. Dioxin/polychlorinated biphenyl body burden, diabetes and endometriosis: findings in a population-based study in Belgium. Biomarkers 2003;8(6):529–34. CrossrefGoogle Scholar

  • 118.

    Longnecker MP, Klebanoff MA, Brock JW, Zhou H, Collaborative Perinatal P. Polychlorinated biphenyl serum levels in pregnant subjects with diabetes. Diabetes Care 2001;24(6):1099–101. CrossrefPubMedGoogle Scholar

  • 119.

    Bertazzi PA, Consonni D, Bachetti S, Rubagotti M, Baccarelli A, Zocchetti C, et al. Health effects of dioxin exposure: a 20-year mortality study. Am J Epidemiol 2001;153(11):1031–44. CrossrefPubMedGoogle Scholar

  • 120.

    Wang SL, Tsai PC, Yang CY, Guo YL. Increased risk of diabetes and polychlorinated biphenyls and dioxins: a 24-year follow-up study of the Yucheng cohort. Diabetes Care 2008;31(8):1574–9. CrossrefPubMedGoogle Scholar

  • 121.

    Vasiliu O, Cameron L, Gardiner J, Deguire P, Karmaus W. Polybrominated biphenyls, polychlorinated biphenyls, body weight, and incidence of adult-onset diabetes mellitus. Epidemiology 2006;17(4):352–9. PubMedCrossrefGoogle Scholar

  • 122.

    Vafeiadi M, Roumeliotaki T, Chalkiadaki G, Rantakokko P, Kiviranta H, Fthenou E, et al. Persistent organic pollutants in early pregnancy and risk of gestational diabetes mellitus. Environ Int 2017;98:89–95. CrossrefPubMedGoogle Scholar

  • 123.

    Eslami B, Naddafi K, Rastkari N, Rashidi BH, Djazayeri A, Malekafzali H. Association between serum concentrations of persistent organic pollutants and gestational diabetes mellitus in primiparous women. Environ Res 2016;151:706–12. PubMedCrossrefGoogle Scholar

  • 124.

    Valvi D, Oulhote Y, Weihe P, Dalgard C, Bjerve KS, Steuerwald U, et al. Gestational diabetes and offspring birth size at elevated environmental pollutant exposures. Environ Int 2017;107:205–15. PubMedCrossrefGoogle Scholar

  • 125.

    Rignell-Hydbom A, Lidfeldt J, Kiviranta H, Rantakokko P, Samsioe G, Agardh CD, et al. Exposure to p,p’-DDE: a risk factor for type 2 diabetes. PLoS One 2009;4(10):e7503. CrossrefGoogle Scholar

  • 126.

    Arrebola JP, Gonzalez-Jimenez A, Fornieles-Gonzalez C, Artacho-Cordon F, Olea N, Escobar-Jimenez F, et al. Relationship between serum concentrations of persistent organic pollutants and markers of insulin resistance in a cohort of women with a history of gestational diabetes mellitus. Environ Res 2015;136:435–40. CrossrefGoogle Scholar

  • 127.

    Rylander C, Sandanger TM, Nost TH, Breivik K, Lund E. Combining plasma measurements and mechanistic modeling to explore the effect of POPs on type 2 diabetes mellitus in Norwegian women. Environ Res 2015;142:365–73. PubMedCrossrefGoogle Scholar

  • 128.

    Wu H, Bertrand KA, Choi AL, Hu FB, Laden F, Grandjean P, et al. Persistent organic pollutants and type 2 diabetes: a prospective analysis in the nurses’ health study and meta-analysis. Environ Health Perspect 2013;121(2):153–61. CrossrefPubMedGoogle Scholar

  • 129.

    Marchand A, Tomkiewicz C, Marchandeau JP, Boitier E, Barouki R, Garlatti M. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces insulin-like growth factor binding protein-1 gene expression and counteracts the negative effect of insulin. Mol Pharmacol 2005;67(2):444–52. PubMedGoogle Scholar

  • 130.

    Dirinck E, Jorens PG, Covaci A, Geens T, Roosens L, Neels H, et al. Obesity and persistent organic pollutants: possible obesogenic effect of organochlorine pesticides and polychlorinated biphenyls. Obesity (Silver Spring) 2011;19(4):709–14. PubMedCrossrefGoogle Scholar

  • 131.

    Lee DH, Lind L, Jacobs DR, Jr., Salihovic S, van Bavel B, Lind PM. Associations of persistent organic pollutants with abdominal obesity in the elderly: The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Environ Int 2012;40:170–8. PubMedCrossrefGoogle Scholar

  • 132.

    Gauthier MS, Rabasa-Lhoret R, Prud’homme D, Karelis AD, Geng D, van Bavel B, et al. The metabolically healthy but obese phenotype is associated with lower plasma levels of persistent organic pollutants as compared to the metabolically abnormal obese phenotype. J Clin Endocrinol Metab 2014;99(6):E1061–6. CrossrefPubMedGoogle Scholar

  • 133.

    Tang-Peronard JL, Heitmann BL, Andersen HR, Steuerwald U, Grandjean P, Weihe P, et al. Association between prenatal polychlorinated biphenyl exposure and obesity development at ages 5 and 7 y: a prospective cohort study of 656 children from the Faroe Islands. Am J Clin Nutr 2014;99(1):5–13. CrossrefGoogle Scholar

  • 134.

    Wahlang B, Beier JI, Clair HB, Bellis-Jones HJ, Falkner KC, McClain CJ, et al. Toxicant-associated steatohepatitis. Toxicol Pathol 2013;41(2):343–60. PubMedCrossrefGoogle Scholar

  • 135.

    Rantakokko P, Mannisto V, Airaksinen R, Koponen J, Viluksela M, Kiviranta H, et al. Persistent organic pollutants and non-alcoholic fatty liver disease in morbidly obese patients: a cohort study. Environ Health 2015;14:79. PubMedCrossrefGoogle Scholar

  • 136.

    Roy AK, Chatterjee B. Sexual dimorphism in the liver. Annu Rev Physiol 1983;45:37–50. CrossrefPubMedGoogle Scholar

  • 137.

    Waxman DJ, Holloway MG. Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol 2009;76(2):215–28. CrossrefPubMedGoogle Scholar

  • 138.

    Deutch B, Hansen JC. High blood levels of persistent organic pollutants are statistically correlated with smoking. Int J Circumpolar Health 1999;58(3):214–19. PubMedGoogle Scholar

  • 139.

    Deutch B, Hansen JC. High human plasma levels of organochlorine compounds in Greenland. Regional differences and lifestyle effects. Dan Med Bull 2000;47(2):132–7. PubMedGoogle Scholar

  • 140.

    Grindler NM, Allsworth JE, Macones GA, Kannan K, Roehl KA, Cooper AR. Persistent organic pollutants and early menopause in U.S. women. PLoS One 2015;10(1):e0116057. CrossrefPubMedGoogle Scholar

  • 141.

    Paunescu AC, Dewailly E, Dodin S, Nieboer E, Ayotte P. Dioxin-like compounds and bone quality in Cree women of Eastern James Bay (Canada): a cross-sectional study. Environ Health 2013;12(1):54. CrossrefGoogle Scholar

  • 142.

    Denham M, Schell LM, Deane G, Gallo MV, Ravenscroft J, DeCaprio AP, et al. Relationship of lead, mercury, mirex, dichlorodiphenyldichloroethylene, hexachlorobenzene, and polychlorinated biphenyls to timing of menarche among Akwesasne Mohawk girls. Pediatrics 2005;115(2):e127–34. PubMedCrossrefGoogle Scholar

  • 143.

    Rogan WJ, Ragan NB. Evidence of effects of environmental chemicals on the endocrine system in children. Pediatrics 2003;112(1 Pt 2):247–52. PubMedGoogle Scholar

  • 144.

    Dudarev AA, Chupakhin VS. Influence of exposure to persistent toxic substances (PTS) on pregnancy outcomes in indigenous females of Chukotka. Gig Sanit 2014(1):36–40. Google Scholar

  • 145.

    Blanck HM, Marcus M, Tolbert PE, Rubin C, Henderson AK, Hertzberg VS, et al. Age at menarche and tanner stage in girls exposed in utero and postnatally to polybrominated biphenyl. Epidemiology 2000;11(6):641–7. CrossrefPubMedGoogle Scholar

  • 146.

    Warner M, Eskenazi B, Olive DL, Samuels S, Quick-Miles S, Vercellini P, et al. Serum dioxin concentrations and quality of ovarian function in women of Seveso. Environ Health Perspect 2007;115(3):336–40. CrossrefPubMedGoogle Scholar

  • 147.

    Yang Q, Zhao Y, Qiu X, Zhang C, Li R, Qiao J. Association of serum levels of typical organic pollutants with polycystic ovary syndrome (PCOS): a case-control study. Hum Reprod 2015;30(8):1964–73. CrossrefPubMedGoogle Scholar

  • 148.

    Gregoraszczuk EL, Ptak A. Endocrine-disrupting chemicals: some actions of POPs on female reproduction. Int J Endocrinol 2013;2013:828532. PubMedGoogle Scholar

  • 149.

    Eskenazi B, Bradman A, Castorina R. Exposures of children to organophosphate pesticides and their potential adverse health effects. Environ Health Perspect 1999;107(Suppl 3):409–19. CrossrefPubMedGoogle Scholar

  • 150.

    Vafeiadi M, Vrijheid M, Fthenou E, Chalkiadaki G, Rantakokko P, Kiviranta H, et al. Persistent organic pollutants exposure during pregnancy, maternal gestational weight gain, and birth outcomes in the mother-child cohort in Crete, Greece (RHEA study). Environ Int 2014;64:116–23. CrossrefPubMedGoogle Scholar

  • 151.

    Fein GG, Jacobson JL, Jacobson SW, Schwartz PM, Dowler JK. Prenatal exposure to polychlorinated biphenyls: effects on birth size and gestational age. J Pediatr 1984;105(2):315–20. CrossrefPubMedGoogle Scholar

  • 152.

    Hertz-Picciotto I, Charles MJ, James RA, Keller JA, Willman E, Teplin S. In utero polychlorinated biphenyl exposures in relation to fetal and early childhood growth. Epidemiology 2005;16(5):648–56. PubMedCrossrefGoogle Scholar

  • 153.

    Govarts E, Nieuwenhuijsen M, Schoeters G, Ballester F, Bloemen K, de Boer M, et al. Birth weight and prenatal exposure to polychlorinated biphenyls (PCBs) and dichlorodiphenyldichloroethylene (DDE): a meta-analysis within 12 European Birth Cohorts. Environ Health Perspect 2012;120(2):162–70. CrossrefPubMedGoogle Scholar

  • 154.

    Wolff MS, Engel S, Berkowitz G, Teitelbaum S, Siskind J, Barr DB, et al. Prenatal pesticide and PCB exposures and birth outcomes. Pediatr Res 2007;61(2):243–50. CrossrefPubMedGoogle Scholar

  • 155.

    Murphy LE, Gollenberg AL, Buck Louis GM, Kostyniak PJ, Sundaram R. Maternal serum preconception polychlorinated biphenyl concentrations and infant birth weight. Environ Health Perspect 2010;118(2):297–302. CrossrefPubMedGoogle Scholar

  • 156.

    Zheng T, Zhang J, Sommer K, Bassig BA, Zhang X, Braun J, et al. Effects of environmental exposures on fetal and childhood growth trajectories. Ann Glob Health 2016;82(1):41–99. PubMedCrossrefGoogle Scholar

  • 157.

    Al-Saleh I, Al-Doush I, Alsabbaheen A, Mohamed Gel D, Rabbah A. Levels of DDT and its metabolites in placenta, maternal and cord blood and their potential influence on neonatal anthropometric measures. Sci Total Environ 2012;416:62–74. CrossrefPubMedGoogle Scholar

  • 158.

    Kezios KL, Liu X, Cirillo PM, Cohn BA, Kalantzi OI, Wang Y, et al. Dichlorodiphenyltrichloroethane (DDT), DDT metabolites and pregnancy outcomes. Reprod Toxicol 2013;35:156–64.CrossrefPubMedGoogle Scholar

  • 159.

    Kumar S. Occupational, environmental and lifestyle factors associated with spontaneous abortion. Reprod Sci 2011;18(10):915–30. PubMedCrossrefGoogle Scholar

  • 160.

    Apelberg BJ, Witter FR, Herbstman JB, Calafat AM, Halden RU, Needham LL, et al. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect 2007;115(11):1670–6. CrossrefPubMedGoogle Scholar

  • 161.

    Darrow LA, Stein CR, Steenland K. Serum perfluorooctanoic acid and perfluorooctane sulfonate concentrations in relation to birth outcomes in the Mid-Ohio Valley, 2005-2010. Environ Health Perspect 2013;121(10):1207–13. PubMedCrossrefGoogle Scholar

  • 162.

    Wu K, Xu X, Peng L, Liu J, Guo Y, Huo X. Association between maternal exposure to perfluorooctanoic acid (PFOA) from electronic waste recycling and neonatal health outcomes. Environ Int 2012;48:1–8. CrossrefPubMedGoogle Scholar

  • 163.

    Harley KG, Chevrier J, Aguilar Schall R, Sjodin A, Bradman A, Eskenazi B. Association of prenatal exposure to polybrominated diphenyl ethers and infant birth weight. Am J Epidemiol 2011;174(8):885–92. PubMedCrossrefGoogle Scholar

  • 164.

    Wu K, Xu X, Liu J, Guo Y, Li Y, Huo X. Polybrominated diphenyl ethers in umbilical cord blood and relevant factors in neonates from Guiyu, China. Environ Sci Technol 2010;44(2):813–9. PubMedCrossrefGoogle Scholar

  • 165.

    Bjerregaard P, Hansen JC. Organochlorines and heavy metals in pregnant women from the Disko Bay area in Greenland. Sci Total Environ 2000;245(1–3):195–202. PubMedCrossrefGoogle Scholar

  • 166.

    Eggesbo M, Stigum H, Longnecker MP, Polder A, Aldrin M, Basso O, et al. Levels of hexachlorobenzene (HCB) in breast milk in relation to birth weight in a Norwegian cohort. Environ Res 2009;109(5):559–66. CrossrefGoogle Scholar

  • 167.

    Ribas-Fito N, Sala M, Cardo E, Mazon C, De Muga ME, Verdu A, et al. Association of hexachlorobenzene and other organochlorine compounds with anthropometric measures at birth. Pediatr Res 2002;52(2):163–7. CrossrefPubMedGoogle Scholar

  • 168.

    Van Tung D, Kido T, Honma S, Manh HD, Nhu DD, Okamoto R, et al. Low birth weight of Vietnamese infants is related to their mother’s dioxin and glucocorticoid levels. Environ Sci Pollut Res Int 2016;23(11):10922–9. CrossrefPubMedGoogle Scholar

  • 169.

    Tsukimori K, Uchi H, Mitoma C, Yasukawa F, Chiba T, Todaka T, et al. Maternal exposure to high levels of dioxins in relation to birth weight in women affected by Yusho disease. Environ Int 2012;38(1):79–86. PubMedCrossrefGoogle Scholar

  • 170.

    Yu ML, Guo YL, Hsu CC, Rogan WJ. Menstruation and reproduction in women with polychlorinated biphenyl (PCB) poisoning: long-term follow-up interviews of the women from the Taiwan Yucheng cohort. Int J Epidemiol 2000;29(4):672–7. PubMedCrossrefGoogle Scholar

  • 171.

    Rogan WJ, Gladen BC, Guo YL, Hsu CC. Sex ratio after exposure to dioxin-like chemicals in Taiwan. Lancet 1999;353(9148):206–7. CrossrefPubMedGoogle Scholar

  • 172.

    del Rio Gomez I, Marshall T, Tsai P, Shao YS, Guo YL. Number of boys born to men exposed to polychlorinated byphenyls. Lancet 2002;360(9327):143–4. PubMedCrossrefGoogle Scholar

  • 173.

    Papadopoulou E, Kogevinas M, Botsivali M, Pedersen M, Besselink H, Mendez MA, et al. Maternal diet, prenatal exposure to dioxin-like compounds and birth outcomes in a European prospective mother-child study (NewGeneris). Sci Total Environ 2014;484:121–8. CrossrefGoogle Scholar

  • 174.

    Papadopoulou E, Caspersen IH, Kvalem HE, Knutsen HK, Duarte-Salles T, Alexander J, et al. Maternal dietary intake of dioxins and polychlorinated biphenyls and birth size in the Norwegian Mother and Child Cohort Study (MoBa). Environ Int 2013;60:209–16. CrossrefPubMedGoogle Scholar

  • 175.

    Halldorsson TI, Meltzer HM, Thorsdottir I, Knudsen V, Olsen SF. Is high consumption of fatty fish during pregnancy a risk factor for fetal growth retardation? A study of 44,824 Danish pregnant women. Am J Epidemiol 2007;166(6):687–96. PubMedCrossrefGoogle Scholar

  • 176.

    Kim S, Park J, Kim HJ, Lee JJ, Choi G, Choi S, et al. Association between several persistent organic pollutants and thyroid hormone levels in serum among the pregnant women of Korea. Environ Int 2013;59:442–8. PubMedCrossrefGoogle Scholar

  • 177.

    Berg V, Nost TH, Pettersen RD, Hansen S, Veyhe AS, Jorde R, et al. Persistent organic pollutants and the association with maternal and infant thyroid homeostasis: a multipollutant assessment. Environ Health Perspect 2017;125(1):127–33. PubMedCrossrefGoogle Scholar

  • 178.

    Eslami B, Malekafzali H, Rastkari N, Rashidi BH, Djazayeri A, Naddafi K. Association of serum concentrations of persistent organic pollutants (POPs) and risk of pre-eclampsia: a case-control study. J Environ Health Sci Eng 2016;14:17. PubMedCrossrefGoogle Scholar

  • 179.

    Bloom MS, Fujimoto VY, Storm R, Zhang L, Butts CD, Sollohub D, et al. Persistent organic pollutants (POPs) in human follicular fluid and in vitro fertilization outcomes, a pilot study. Reprod Toxicol 2017;67:165–73. CrossrefPubMedGoogle Scholar

  • 180.

    Robledo CA, Yeung E, Mendola P, Sundaram R, Maisog J, Sweeney AM, et al. Preconception maternal and paternal exposure to persistent organic pollutants and birth size: the LIFE study. Environ Health Perspect 2015;123(1):88–94. CrossrefPubMedGoogle Scholar

  • 181.

    Casas M, Nieuwenhuijsen M, Martinez D, Ballester F, Basagana X, Basterrechea M, et al. Prenatal exposure to PCB-153, p,p’-DDE and birth outcomes in 9000 mother-child pairs: exposure-response relationship and effect modifiers. Environ Int 2015;74:23–31. PubMedCrossrefGoogle Scholar

  • 182.

    Callan AC, Hinwood AL, Heyworth J, Phi DT, Odland JO. Sex specific influence on the relationship between maternal exposures to persistent chemicals and birth outcomes. Int J Hyg Environ Health 2016;219(8):734–41. PubMedCrossrefGoogle Scholar

  • 183.

    Vafeiadi M, Agramunt S, Pedersen M, Besselink H, Chatzi L, Fthenou E, et al. In utero exposure to compounds with dioxin-like activity and birth outcomes. Epidemiology 2014;25(2):215–24. CrossrefPubMedGoogle Scholar

  • 184.

    Araki A, Miyashita C, Mitsui T, Goudarzi H, Mizutani F, Chisaki Y, et al. Prenatal organochlorine pesticide exposure and the disruption of steroids and reproductive hormones in cord blood: The Hokkaido study. Environ Int 2018;110:1–13. PubMedCrossrefGoogle Scholar

  • 185.

    Rogan WJ, Gladen BC, Hung KL, Koong SL, Shih LY, Taylor JS, et al. Congenital poisoning by polychlorinated biphenyls and their contaminants in Taiwan. Science 1988;241(4863):334–6. CrossrefPubMedGoogle Scholar

  • 186.

    Guo YL, Lambert GH, Hsu CC, Hsu MM. Yucheng: health effects of prenatal exposure to polychlorinated biphenyls and dibenzofurans. Int Arch Occup Environ Health 2004;77(3):153–8. CrossrefPubMedGoogle Scholar

  • 187.

    Hsu MM, Mak CP, Hsu CC. Follow-up of skin manifestations in Yu-Cheng children. Br J Dermatol 1995;132(3):427–32. PubMedCrossrefGoogle Scholar

  • 188.

    Gladen BC, Taylor JS, Wu YC, Ragan NB, Rogan WJ, Hsu CC. Dermatological findings in children exposed transplacentally to heat-degraded polychlorinated biphenyls in Taiwan. Br J Dermatol 1990;122(6):799–808. PubMedCrossrefGoogle Scholar

  • 189.

    Dewailly E, Ayotte P, Bruneau S, Gingras S, Belles-Isles M, Roy R. Susceptibility to infections and immune status in Inuit infants exposed to organochlorines. Environ Health Perspect 2000;108(3):205–11. CrossrefPubMedGoogle Scholar

  • 190.

    Weisglas-Kuperus N, Sas TC, Koopman-Esseboom C, van der Zwan CW, De Ridder MA, Beishuizen A, et al. Immunologic effects of background prenatal and postnatal exposure to dioxins and polychlorinated biphenyls in Dutch infants. Pediatr Res 1995;38(3):404–10. PubMedCrossrefGoogle Scholar

  • 191.

    Koopman-Esseboom C, Weisglas-Kuperus N, de Ridder MA, Van der Paauw CG, Tuinstra LG, Sauer PJ. Effects of polychlorinated biphenyl/dioxin exposure and feeding type on infants’ mental and psychomotor development. Pediatrics 1996;97(5):700–6. PubMedGoogle Scholar

  • 192.

    Vreugdenhil HJ, Lanting CI, Mulder PG, Boersma ER, Weisglas-Kuperus N. Effects of prenatal PCB and dioxin background exposure on cognitive and motor abilities in Dutch children at school age. J Pediatr 2002;140(1):48–56. CrossrefPubMedGoogle Scholar

  • 193.

    Daniels JL, Longnecker MP, Klebanoff MA, Gray KA, Brock JW, Zhou H, et al. Prenatal exposure to low-level polychlorinated biphenyls in relation to mental and motor development at 8 months. Am J Epidemiol 2003;157(6):485–92. PubMedCrossrefGoogle Scholar

  • 194.

    Jacobson JL, Jacobson SW, Humphrey HE. Effects of in utero exposure to polychlorinated biphenyls and related contaminants on cognitive functioning in young children. J Pediatr 1990;116(1):38–45. PubMedCrossrefGoogle Scholar

  • 195.

    Gascon M, Fort M, Martinez D, Carsin AE, Forns J, Grimalt JO, et al. Polybrominated diphenyl ethers (PBDEs) in breast milk and neuropsychological development in infants. Environ Health Perspect 2012;120(12):1760–5. PubMedCrossrefGoogle Scholar

  • 196.

    Eskenazi B, Marks AR, Bradman A, Fenster L, Johnson C, Barr DB, et al. In utero exposure to dichlorodiphenyltrichloroethane (DDT) and dichlorodiphenyldichloroethylene (DDE) and neurodevelopment among young Mexican American children. Pediatrics 2006;118(1):233–41. CrossrefPubMedGoogle Scholar

  • 197.

    Strom M, Hansen S, Olsen SF, Haug LS, Rantakokko P, Kiviranta H, et al. Persistent organic pollutants measured in maternal serum and offspring neurodevelopmental outcomes--a prospective study with long-term follow-up. Environ Int 2014;68:41–8. PubMedCrossrefGoogle Scholar

  • 198.

    Jacobson JL, Jacobson SW. Intellectual impairment in children exposed to polychlorinated biphenyls in utero. N Engl J Med 1996;335(11):783–9. CrossrefPubMedGoogle Scholar

  • 199.

    Thundiyil JG, Solomon GM, Miller MD. Transgenerational exposures: persistent chemical pollutants in the environment and breast milk. Pediatr Clin North Am 2007;54(1):81–101, ix. CrossrefPubMedGoogle Scholar

  • 200.

    Landrigan PJ. Pesticides and polychlorinated biphenyls (PCBs): an analysis of the evidence that they impair children’s neurobehavioral development. Mol Genet Metab 2001;73(1):11–17. CrossrefPubMedGoogle Scholar

  • 201.

    Hansen S, Strom M, Olsen SF, Dahl R, Hoffmann HJ, Granstrom C, et al. Prenatal exposure to persistent organic pollutants and offspring allergic sensitization and lung function at 20 years of age. Clin Exp Allergy 2016;46(2):329–36. PubMedCrossrefGoogle Scholar

  • 202.

    Hsu PC, Lai TJ, Guo NW, Lambert GH, Guo YL. Serum hormones in boys prenatally exposed to polychlorinated biphenyls and dibenzofurans. J Toxicol Environ Health A 2005;68(17–18):1447–56. CrossrefPubMedGoogle Scholar

  • 203.

    Rogan WJ, Ragan NB. Some evidence of effects of environmental chemicals on the endocrine system in children. Int J Hyg Environ Health 2007;210(5):659–67. CrossrefPubMedGoogle Scholar

  • 204.

    Kelce WR, Stone CR, Laws SC, Gray LE, Kemppainen JA, Wilson EM. Persistent DDT metabolite p,p’-DDE is a potent androgen receptor antagonist. Nature 1995;375(6532):581–5. PubMedCrossrefGoogle Scholar

  • 205.

    Yard EE, Terrell ML, Hunt DR, Cameron LL, Small CM, McGeehin MA, et al. Incidence of thyroid disease following exposure to polybrominated biphenyls and polychlorinated biphenyls, Michigan, 1974–2006. Chemosphere 2011;84(7):863–8. PubMedCrossrefGoogle Scholar

  • 206.

    Vahter M, Berglund M, Akesson A, Liden C. Metals and women’s health. Environ Res 2002;88(3):145–55. CrossrefPubMedGoogle Scholar

  • 207.

    Sidiropoulos K, Viteri G, Sevilla C, Jupe S, Webber M, Orlic-Milacic M, et al. Reactome enhanced pathway visualization. Bioinformatics 2017;33(21):3461–7. CrossrefPubMedGoogle Scholar

  • 208.

    Nault R, Fader KA, Harkema JR, Zacharewski T. Loss of liver-specific and sexually dimorphic gene expression by aryl hydrocarbon receptor activation in C57BL/6 mice. PLoS One 2017;12(9):e0184842. CrossrefPubMedGoogle Scholar

About the article

Corresponding author: Banrida Wahlang, PhD, Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Louisville School of Medicine, 505 S. Hancock Street, CTRB, Louisville, KY 40202-1617, USA, Phone: +502 852-3912, Fax: +502 852-8927


Received: 2018-03-24

Accepted: 2018-07-18

Published Online: 2018-08-15

Published in Print: 2018-12-19


Research funding: Author states no funding involved.

Conflict of interest: The author has no actual or potential competing conflict of interest relevant to this work.

Informed consent: Informed consent is not applicable.

Ethical approval: The conducted research is not related to either human or animal use.


Citation Information: Reviews on Environmental Health, Volume 33, Issue 4, Pages 331–348, ISSN (Online) 2191-0308, ISSN (Print) 0048-7554, DOI: https://doi.org/10.1515/reveh-2018-0018.

Export Citation

©2018 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in